Bibliografia UJ CM

1/4
P. Berlanga, C. Pasqualini, U. Potschger, C. Sanguesa, M.R. Castellani, A. Canete, R. Luksch, M. Elliot, G. Schreier, M. Kropf, D. Morgenstern, V. Papadakis, S. Ash, E. Ruud, P. Brock, A[leksandra] Wieczorek, P. Kogner, T. Trahair, P. Ambros, T. Boterberg, V. Castel, D. Valteau-Couanet, R. Ladenstein.
Central nervous system relapse in high-risk stage 4 neuroblastoma : The HR-NBL1/SIOPEN trial experience.
European Journal of Cancer
2021 : Vol. 144, s. 1-8, il., bibliogr. 17 poz., abstr.
Autor korespondencyjny: P. Berlanga.
Open Access Creative Commons Attribution License CC-BY-NC-ND 4.0.
p-ISSN: 0959-8049
AZ
ORG
AIF
IF: 10.002
Adres url:
Streszczenie w PubMed:
2/4
R. Ladenstein, U. Poetschger, T. Boterberg, K. Dieckmann, S. Bolle, K. Holmes, S. Sarnacki, J. Gomez-Chacon, P. Brock, R. Luksch, S. Ash, W[alentyna] Balwierz, E. Ruud, V. Papadakis, C. Owens, J. Stenman, H. Schroeder, T. Trahair, D. Valteau-Couanet, M. Gaze.
Success of the HR-NBL1/SIOPEN Trial Local Control Strategy in High-Risk Neuroblastoma Patients Receiving High-Dose Therapy and Stem Cell Transplantation.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S261-S262, abstr. PO-372.
p-ISSN: 1545-5009
SZZ
SIF
3/4
R. Ladenstein, U. Poetschger, D. Valteau-Couanet, V. Castel, M. Elliott, S. Ash, G. Chan, G. Laureys, M. Beck-Popovic, K. Vettenranta, W[alentyna] Balwierz, H. Schroeder, C. Owens, M. Cesen, V. Papadakis, T. Trahair, R. Luksch, G. Schleiermacher, P. Ambros, A. Garaventa.
The Randomised Induction for High-Risk Neuroblastoma Comparing COJEC and N5-MSKCC Regimens. Early Results from the HR-NBL1.5/SIOPEN Trial.
Pediatric Blood & Cancer
2018 : Vol. 65, suppl. 2, s. S11, abstr. O-013.
p-ISSN: 1545-5009
SZZ
SIF
4/4
R. Ladenstein, U. Poetschger, M. Elliot, R. Luksch, V. Castel, I. Yaniv, V. Papadakis, G. Laureys, J. Malis, W[alentyna] Balwierz, E. Ruud, P. Kogner, H. Schroeder, A. Forjaz de Lacerda, M. Beck-Popovic, P. Bician, M. Garami, T. Trahair, P. Ambros, K. Holmes, G. Schreier, M. Gaze, A. Pearson, D. Valteau-Couanet, SIOP Europe Neuroblastoma Grp.
Risk factors in stage 4 neuroblastoma patients treated with Busulphan-Melphalan. Report from the European High Risk Neuroblastoma HR-NBL1/SIOPEN TRIAL.
Bone Marrow Transplantation
2016 : Vol. 51, suppl. 1, s. S46, abstr. O072.
42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, APR 03-06, 2016.
p-ISSN: 0268-3369
SZZ
SIF
Wyświetl ponownie stosując format:

Wyświetl/ukryj etykiety | Wyświetlenie wyników w wersji do druku | Pobranie pliku do edytora | Nowe wyszukiwanie | Biblioteka Medyczna UJ